Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Mali: A Randomised, Double-Blind, Placebo-Controlled Trial
2011

IPTc Reduces Malaria in Children with Bednets in Mali

Sample size: 3017 publication 10 minutes Evidence: high

Author Information

Author(s): Dicko Alassane, Diallo Abdoulbaki I., Tembine Intimbeye, Dicko Yahia, Dara Niawanlou, Sidibe Youssoufa, Santara Gaoussou, Diawara Halimatou, Conaré Toumani, Djimde Abdoulaye, Chandramohan Daniel, Cousens Simon, Milligan Paul J., Diallo Diadier A., Doumbo Ogobara K., Greenwood Brian

Primary Institution: Malaria Research and Training Centre, Faculty of Medicine Pharmacy and Dentistry, University of Bamako, Bamako, Mali

Hypothesis

Does intermittent preventive treatment of malaria (IPTc) provide additional protection to children sleeping under insecticide-treated nets (ITNs)?

Conclusion

IPTc during the malaria transmission season provided substantial protection against clinical malaria, malaria infection, and anaemia in children using long-lasting insecticide-treated nets.

Supporting Evidence

  • 672 episodes of clinical malaria were observed in the control arm versus 126 in the intervention arm.
  • IPTc reduced the prevalence of malaria infection by 85% during the intervention period.
  • IPTc reduced the prevalence of moderate anaemia by 47% at the end of the intervention period.
  • Adverse events were similar between the two arms, with no drug-related serious adverse events.
  • IPTc provided a protective efficacy of 82% against clinical malaria.
  • 1,485 children (98.5%) in the control arm and 1,481 (98.1%) in the intervention arm completed follow-up.
  • 99.7% of children in the control arm and 99.3% in the intervention arm reported sleeping under an ITN.

Takeaway

Giving special medicine to kids during the malaria season helps keep them safe from getting sick, even if they sleep under mosquito nets.

Methodology

A randomized, double-blind, placebo-controlled trial was conducted with children aged 3-59 months receiving IPTc with SP+AQ or placebos during the malaria transmission season.

Potential Biases

Potential biases in participant selection and outcome assessment were minimized by the double-blind design.

Limitations

The study focused only on the malaria transmission season and did not assess long-term effects beyond this period.

Participant Demographics

Children aged 3-59 months from rural villages in Mali.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI 78%–85%

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pmed.1000407

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication